{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T11:10:29Z","timestamp":1656673829563},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T00:00:00Z","timestamp":1431475200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s11940-015-0353-6","type":"journal-article","created":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T00:35:13Z","timestamp":1431390913000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Treatment of Headache Following Triptan Failure After Successful Triptan Therapy"],"prefix":"10.1007","volume":"17","author":[{"given":"Marc E. P.","family":"Lenaerts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"James R.","family":"Couch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,13]]},"reference":[{"key":"353_CR1","doi-asserted-by":"crossref","unstructured":"Loder E. Triptan therapy in migraine. N Engl J Med. 2010;363:63\u201370. Class I, Excellent review and reference in the field.","DOI":"10.1056\/NEJMct0910887"},{"key":"353_CR2","doi-asserted-by":"crossref","unstructured":"Evans RW, Tepper SJ, Shapiro RE, Sun-Edelstein C, Tietjen GE. The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American headache society position paper. Headache. 2010;50:1089\u201399. Class III.","DOI":"10.1111\/j.1526-4610.2010.01691.x"},{"key":"353_CR3","doi-asserted-by":"crossref","unstructured":"Blumenfeld A, Gennings C, Cady R. Pharmacological synergy: the next frontier on therapeutic advancement for migraine. Headache. 2012;52:636\u201347. Class IV.","DOI":"10.1111\/j.1526-4610.2011.02058.x"},{"key":"353_CR4","doi-asserted-by":"crossref","unstructured":"Newman LC. Why triptan treatment can fail: focus on gastrointestinal manifestations of migraine. Headache. 2013;53:S11\u20136. Class IV.","DOI":"10.1111\/head.12111"},{"key":"353_CR5","doi-asserted-by":"crossref","unstructured":"Goldstein J, Smith TR, Pugash N, et al. A Sumatriptan iontophoretic transdermal system for the acute treatment of migraine. Headache. 2012;52:1402\u201310. Class I.","DOI":"10.1111\/j.1526-4610.2012.02198.x"},{"key":"353_CR6","doi-asserted-by":"crossref","unstructured":"Raskin NH. Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology. 1986;36:995\u20137. Class III.","DOI":"10.1212\/WNL.36.7.995"},{"key":"353_CR7","doi-asserted-by":"crossref","unstructured":"Callaham M, Raskin N. A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache. 1986;26:168\u201371. Class I.","DOI":"10.1111\/j.1526-4610.1986.hed2604168.x"},{"key":"353_CR8","doi-asserted-by":"crossref","unstructured":"Saadah H. Abortive headache therapy with intramuscular dihydroergotamine. Headache. 1992;32:18\u201320. Class III.","DOI":"10.1111\/j.1526-4610.1992.hed3201018.x"},{"key":"353_CR9","doi-asserted-by":"crossref","unstructured":"Weisz MA1, el-Raheb M, Blumenthal HJ. Home administration of intramuscular DHE for the treatment of acute migraine headache. Headache. 1994;34:371\u20133. Class II.","DOI":"10.1111\/j.1526-4610.1994.hed3406371.x"},{"key":"353_CR10","doi-asserted-by":"crossref","unstructured":"Becker WJ, Riess CM, Hoag G. Efficacy of sub-cutaneous dihydroergotamine by home injections in migraine. Headache. 1996;36:144\u20138. Class III.","DOI":"10.1046\/j.1526-4610.1996.3603144.x"},{"key":"353_CR11","doi-asserted-by":"crossref","unstructured":"Saper JR, Silberstein S. Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine. Headache. 2006;46:S171\u201381. Class IV.","DOI":"10.1111\/j.1526-4610.2006.00601.x"},{"key":"353_CR12","doi-asserted-by":"crossref","unstructured":"Tfelt-Hansen P, Diener HC. Use of dihydroergotamine (DHE) should be restricted to no more than twice a week. Headache. 2014. Class IV.","DOI":"10.1111\/head.12389"},{"key":"353_CR13","doi-asserted-by":"crossref","unstructured":"Ziegler D, Ford R, Kriegler J, Gallagher RM, Peroutka S, Hammerstad J, et al. Dihydroergotamine nasal spray for the acute treatment of migraine. Neurology. 1994;44:447\u201353. Class I.","DOI":"10.1212\/WNL.44.3_Part_1.447"},{"key":"353_CR14","doi-asserted-by":"crossref","unstructured":"Ghallager GM. Acute treatment of migraine with dihydroergotamine nasal spray. Dihydroergotamine Working Group. Arch Neurol. 1996;53(12):1285\u201391. Class I.","DOI":"10.1001\/archneur.1996.00550120097022"},{"key":"353_CR15","doi-asserted-by":"crossref","unstructured":"Aurora SK, Silberstein SD, Kori SH, Tepper SJ, Borland SW, Wang M, et al. MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine. Headache. 2011;51(4):507\u201317. Class I.","DOI":"10.1111\/j.1526-4610.2011.01869.x"},{"key":"353_CR16","doi-asserted-by":"crossref","unstructured":"Law S, Derry S, Moore RA. Naproxen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2013;20:10. Class I.","DOI":"10.1002\/14651858.CD009455.pub2"},{"key":"353_CR17","unstructured":"Loo CY, Tan HJ, Tay HS, Raymond AA. Randomized, open label, controlled trial of celecoxib in the treatment of acute migraine. Singapore Med J. 2007;48:834\u20139. Class II."},{"key":"353_CR18","doi-asserted-by":"crossref","unstructured":"Lipton RB, Grosberg B, Singer RP, et al. Efficacy and tolerability of a new powdered formulation of diclofenac potassium for oral solution for the acute treatment of migraine: results from the International Migraine Pain Assessment Clinical Trial (IMPACT). Cephalalgia. 2010;30:1336\u201345. Class I.","DOI":"10.1177\/0333102410367523"},{"key":"353_CR19","doi-asserted-by":"crossref","unstructured":"The Diclofenac-K\/Sumatriptan Migraine Study Group. Acute treatment of migraine attacks: efficacy and safety of a non-steroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. Cephalalgia. 1999;19:232\u201340. Class I.","DOI":"10.1046\/j.1468-2982.1999.019004232.x"},{"key":"353_CR20","doi-asserted-by":"crossref","unstructured":"Meredith JT, Wait S, Brewer KL. A prospective double-blind study of nasal sumatriptan versus IV ketorolac in migraine. Am J Emerg Med. 2003;21:173\u20135. Class I.","DOI":"10.1016\/S0735-6757(02)42256-5"},{"key":"353_CR21","doi-asserted-by":"crossref","unstructured":"Pfaffenrath V, Fenzl E, Bergman D, et al. Intranasal ketorolac tromethamine (SPRIX\u00ae) containing 6% of lidocaine (ROX-828) for acute treatment of migraine: safety and efficacy data from a phase II clinical trial. Cephalalgia. 2012;32:766\u201377. Class I.","DOI":"10.1177\/0333102412451359"},{"key":"353_CR22","doi-asserted-by":"crossref","unstructured":"Diamond S. Treatment of migraine with isometheptene, acetaminophen, and dichloralphenazone combination: a double-blind, crossover trial. Headache. 1976;15(4):282\u20137. Class II.","DOI":"10.1111\/j.1526-4610.1976.hed1504282.x"},{"key":"353_CR23","doi-asserted-by":"crossref","unstructured":"Freitag FG, Cady R, DiSerio F, Elkind A, Gallagher RM, Goldstein J, et al. Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine. Headache. 2001;41(4):391\u20138. Class I.","DOI":"10.1046\/j.1526-4610.2001.111006391.x"},{"key":"353_CR24","doi-asserted-by":"crossref","unstructured":"Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies. Headache. 2015;55(1):3\u201320. Class I, A critical appraisal of current headache care practice in the US.","DOI":"10.1111\/head.12499"},{"key":"353_CR25","doi-asserted-by":"crossref","unstructured":"Choi H, Parmar N. The use of intravenous magnesium sulphate for acute migraine: meta-analysis of randomized controlled trials. Eur J Emerg Med. 2014;21(1):2\u20139. Class I.","DOI":"10.1097\/MEJ.0b013e3283646e1b"},{"key":"353_CR26","doi-asserted-by":"crossref","unstructured":"Edwards KR, Norton J, Behnke M. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. Headache. 2001;41(10):976\u201380. Class II.","DOI":"10.1046\/j.1526-4610.2001.01191.x"},{"key":"353_CR27","doi-asserted-by":"crossref","unstructured":"Mathew NT, Kailasam J, Meadors L, Chernyschev O, Gentry P. Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report. Headache. 2000;40(9):720\u20133. Class II.","DOI":"10.1046\/j.1526-4610.2000.00125.x"},{"key":"353_CR28","unstructured":"Starling AJ, Dodick DW, Chiacchierini RP (2011) Comparison of effect size between active and placebo for single pulse transcranial magnetic stimulation (spTMS) versus triptans for the acute treatment of migraine. Poster, AAN Proceedings, Honolulu, USA, Class III"},{"key":"353_CR29","doi-asserted-by":"crossref","unstructured":"Bhola R, Kinsella E, Goadsby PJ (2013) Update of the UK post market pilot programme with single pulse transcranial magnetic stimulation (sTMS) for acute treatment of migraine: SpringTMS use in migraine. Poster, International Headache Congress, Boston, USA, Class III","DOI":"10.1186\/1129-2377-15-S1-M2"},{"key":"353_CR30","doi-asserted-by":"crossref","unstructured":"Schoenen J, Vandersmissen B, Jeangette S, Herroelen L, Vandenheede M, Gerard P, et al. Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology. 2013;80(8):697\u2013704. Class I.","DOI":"10.1212\/WNL.0b013e3182825055"},{"key":"353_CR31","doi-asserted-by":"crossref","unstructured":"Magis D, Sava S, d\u2019Elia Sasso T, Baschi R, Schoenen J. Safety and patients\u2019 satisfaction of transcutaneous supraorbital neurostimulation (tSNS) with the Cefaly\u00ae device in headache treatment: a survey of 2,313 headache sufferers in the general population. J Headache Pain. 2013;14:95. Class II.","DOI":"10.1186\/1129-2377-14-95"},{"key":"353_CR32","doi-asserted-by":"crossref","unstructured":"Lenaerts ME, Oommen KJ, Couch JR, Skaggs V. Can vagus nerve stimulation help migraine? Cephalalgia. 2008;28:392\u20135. Class III.","DOI":"10.1111\/j.1468-2982.2008.01538.x"},{"key":"353_CR33","doi-asserted-by":"crossref","unstructured":"Goadsby PJ, Grosberg BM, Mauskop A, Cady R, Simmons KA. Effect of non-invasive vagus nerve stimulation on acute migraine: an open-label pilot study. Cephalalgia. 2014;34:986\u201393. Class III.","DOI":"10.1177\/0333102414524494"},{"key":"353_CR34","doi-asserted-by":"crossref","unstructured":"Cady R, Saper J, Dexter K, Manley HR. A double-blind, placebo-controlled study of repetitive transnasal spheno-palatine ganglion blockade with tx360 as acute treatment for chronic migraine. Headache. 2015;55(1):101\u201316. Class I.","DOI":"10.1111\/head.12458"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-015-0353-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-015-0353-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-015-0353-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-015-0353-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T01:08:04Z","timestamp":1581988084000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-015-0353-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,13]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["353"],"URL":"https:\/\/doi.org\/10.1007\/s11940-015-0353-6","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,13]]},"assertion":[{"value":"13 May 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"27"}}